Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Strontium-89 Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Q BioMed Launches New Website Strontium89.com and Digital for Strontium89
    Q BioMed Launches New Website Strontium89.com and Digital for Strontium89

    15 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/q-biomed-launches-new-website-strontium89com-and-digital-marketing-campaign-for-strontium89-strontium-chloride-sr-89-injection-usp-non-opioid-treatment-for-metastatic-bone-pain-301059967.html

    PRNEWSWIRE
    15 May 2020
    Share Share
    Q BioMed Launches Non-opioid Treatment for Metastatic Bone Pain
    Q BioMed Launches Non-opioid Treatment for Metastatic Bone Pain

    13 Feb 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q-biomed-launches-non-opioid-treatment-for-metastatic-bone-pain-301003993.html

    PR NEWSWIRE
    13 Feb 2020
    Share Share
    Q BioMed Announces Commercial Partnership With Jubilant Radiopharma
    Q BioMed Announces Commercial Partnership With Jubilant Radiopharma

    07 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/q-biomed-announces-commercial-partnership-with-jubilant-radiopharma-for-the-distribution-of-its-non-opioid-cancer-palliation-drug-in-the-united-states/

    BIOSPACE
    07 Oct 2019
    Share Share
    Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP
    Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP

    20 Aug 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q-biomed-inc-announces-fda-filing-for-strontium-chloride-sr89-injection-usp-for-relief-of-metastatic-cancer-bone-pain-300699377.html

    PR NEWSWIRE
    20 Aug 2018
    Share Share